Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

Boeing Company (The) (BA)

2026-08-03T15:18:17.223592+00:00

Executive Summary

Boeing shares have rebounded 6.33% to $226.54 since the July 31 report, driven by record Q2 backlog, positive cash flow generation, and a dominant Farnborough Airshow showing with 173 orders. While the near-term momentum has shifted positively and YTD performance has improved to +4.34%, the company remains in a loss position and management has signaled that financial stabilization will take "a couple more years" before any new aircraft program launch.

Key Updates

Since the last report on July 31, when shares closed at $213.05 following a 2.93% decline, Boeing has staged a sharp recovery. The stock has gained 6.33% to $226.54, with particularly strong momentum over the past five sessions (+7.11%) and a robust 4.81% single-day advance. This rebound erases the late-July losses and restores YTD performance to +4.34%, though the 6-month return remains negative at -2.84%. The price action suggests the market has absorbed Q2 earnings and Farnborough order flow more favorably after an initial negative reaction, with investors focusing on record backlog and improved cash generation rather than near-term GAAP losses.

Current Trend

Boeing's YTD performance stands at +4.34%, reflecting a modest but positive annual trajectory. The one-month return is essentially flat at +0.02%, indicating that the recent 5-day surge of +7.11% has been the primary driver of year-to-date gains. Over six months, the stock is down -2.84%, confirming that the current rally is occurring within a broader consolidation phase. The sharp rebound from the July 31 low near $213 establishes this level as near-term support, while the July 30 high around $219 has been reclaimed. The next technical resistance zone is likely the Morningstar fair value estimate of $246, which was raised from $238 following Q2 results and represents the closest fundamental benchmark above current levels.

Investment Thesis

The investment thesis rests on Boeing's ability to execute an operational turnaround under CEO Kelly Ortberg, convert its record $715 billion backlog into sustained free cash flow, and restore profitability across the Commercial Airplanes segment. The company generated $1.4 billion in operating cash flow and $0.6 billion in free cash flow in Q2 2026, with management targeting approximately $1.5 billion in free cash flow for the full year and a path toward exceeding $10 billion by 2028. Critical to this thesis is the production ramp of the 737 program—representing roughly half of enterprise value—from 42 to 47 aircraft per month by late 2026, alongside upcoming certifications for the 737 MAX-7, MAX-10, and 777X. Global Services provides a stabilizing margin contribution at 18.1%, while Defense, Space & Security offers revenue diversification despite program-specific charges. The company maintains a robust liquidity position with $20.0 billion in cash and investments and $10.0 billion in undrawn credit facilities, providing financial flexibility as it invests $1 billion to expand 737 production into Everett.

Thesis Status

The investment thesis remains intact but is advancing incrementally. The Q2 2026 results and Farnborough order victory validate the operational recovery narrative, particularly the 173 aircraft orders surpassing Airbus for the first time in four years and the reduction in 737 defect-related labor time by nearly 20%. However, the thesis is not yet de-risked: the Commercial Airplanes segment posted a (2.7)% operating margin, the company recorded a GAAP loss of ($0.67) per share, and CEO Ortberg has explicitly stated that Boeing requires "a couple more years" to repair finances before launching a new commercial aircraft. The near-term stock recovery aligns with improved execution, but consistent profitability in the commercial unit is not expected in the immediate future due to the Everett expansion investment. The status is one of cautious progression toward turnaround milestones rather than confirmed inflection.

Key Drivers

Primary catalysts include the production ramp and certification timeline for the 737 MAX family and 777X, which management expects later in 2026 and which underpin the $1.5 billion 2026 free cash flow target. The Farnborough International Airshow resulted in 173 orders, including 100 planes from lessor SMBC Aviation and 28 Boeing 787s for Riyadh Air, demonstrating renewed airline confidence. On the defense side, the Air Force One replacement program incurred a $280 million charge, contributing to the segment's $15 million operating loss despite 13% revenue growth. Quality improvements on the 737 line, including a 40% reduction in fuselage defects, are supporting operational efficiency. Conversely, Emirates President Tim Clark stated the airline would reject the first 10 delayed 777X jets expected in 2027, highlighting execution risk on widebody deliveries. The CEO's guidance that no new clean-sheet aircraft will be launched until finances are repaired removes near-term R&D risk but also delays long-term product competitiveness against Airbus's A320 family.

Technical Analysis

The current price action reflects a decisive breakout from the late-July consolidation. Having closed at $213.05 on July 31, the stock has surged to $226.54, reclaiming the $219.48 level from July 30 and establishing a higher low. Volume-supported momentum over the past five sessions (+7.11%) suggests institutional participation. Immediate support is now the July 31 low near $213, with secondary support at the psychological $220 level. Resistance is anticipated near the Morningstar fair value estimate of $246, approximately 8.6% above current levels. The 6-month downtrend from February highs is being challenged, but a sustained move above $230 would be required to confirm a broader trend reversal. YTD performance turning positive at +4.34% improves the intermediate-term outlook, though the stock remains below levels required to erase 6-month losses.

Bull Case

  • Record backlog of $715 billion, including over 6,200 commercial airplanes valued at $597 billion, provides multi-year revenue visibility and underpins the path to $10 billion free cash flow by 2028. Source
  • Boeing secured 173 aircraft orders at Farnborough, surpassing Airbus's 154 deals and marking its first victory at a major airshow in four years, signaling renewed customer confidence in the turnaround. Source
  • Q2 2026 operating cash flow of $1.4 billion and free cash flow of $0.6 billion demonstrate positive cash generation, while the company holds $20.0 billion in cash and investments plus $10.0 billion in undrawn credit facilities. Source
  • Quality improvements have reduced defect-related labor time on the 737 line by nearly 20% and fuselage defects by 40%, supporting the production increase from 42 to 47 aircraft per month by late 2026. Source
  • Morningstar raised its fair value estimate to $246 from $238, noting the stock trades within 10% of this valuation, while management targets certification of the 737 MAX-7, MAX-10, and 777X later in 2026 to unlock further value. Source

Bear Case

  • The company posted a Q2 GAAP loss of ($0.67) per share and a core loss of ($0.76) per share, with the Commercial Airplanes segment operating at a (2.7)% margin, indicating persistent profitability challenges. Source
  • CEO Kelly Ortberg stated Boeing needs "a couple more years" to repair finances before committing to a new commercial aircraft, delaying long-term product competitiveness against Airbus and underscoring the depth of remaining financial strain. Source
  • The Defense, Space & Security segment posted a $15 million operating loss due to a $280 million charge on the Air Force One replacement program, exposing the segment to fixed-price contract risk. Source
  • Emirates President Tim Clark stated the airline would reject the first 10 delayed 777X jets expected in 2027, highlighting customer frustration and execution risk on critical widebody deliveries. Source
  • Boeing's commercial plane unit is not expected to generate consistent profits in the near term, due in part to a $1 billion investment to expand 737 production into Everett, which will pressure margins during the critical production ramp toward 52 aircraft per month. Source
  • Boeing continues to trail Airbus in annual order volume despite the Farnborough victory, indicating that market share erosion persists even as execution improves. Source

>

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.